[Investigation of potency to produce interleukin-2 of the peripheral blood T lymphocytes in patients with hemorrhagic stroke].
For further understanding the changes in immune function of the patients with hemorrhagic stroke, we investigated the activity of interleukin-2 (IL-2) in the peripheral blood T lymphocytes from 32 patients. The results showed that the levels of IL-2 in the patients were lower than those of the healthy controls, but no significant difference was observed between the cerebral hemorrhage group and subarachnoid hemorrhage group. It suggests the cellular immune function of patients at the acute period is low. We consider that IL-2 might be of use as a kind of therapeutic measure to modulate patients' immune function and treat the diseases.
Zou
X
X
Department of Neurology, First Affiliated Hospital, Chengdu.
Fang
S
S
Yuan
G
G
Shen
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers; D002543:Cerebral Hemorrhage / Q000276:immunology*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013345:Subarachnoid Hemorrhage / Q000276:immunology*; D013601:T-Lymphocytes / Q000378:metabolism
D015415:Biomarkers; D007376:Interleukin-2